rly-4008
relay therapeutics
['rly-4008']
late breaking data presented at esmo congress 2022 demonstrate potential of rly-4008 to transform treatment options for cholangiocarcinoma patients with fgfr2-driven disease 
Pharmaceutical News - Direct Information